Circulating miRNA as a Biomarker in Oral Cancer Liquid Biopsy

Oral cancer is currently challenging the healthcare system, with a high incidence among the population and a poor survival rate. One of the main focuses related to this malignancy is the urge to implement a viable approach for improving its early diagnosis. By introducing the use of liquid biopsy an...

Full description

Bibliographic Details
Main Authors: Alexandra Roi, Simina Boia, Laura-Cristina Rusu, Ciprian Ioan Roi, Eugen Radu Boia, Mircea Riviș
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/3/965
_version_ 1827751128404590592
author Alexandra Roi
Simina Boia
Laura-Cristina Rusu
Ciprian Ioan Roi
Eugen Radu Boia
Mircea Riviș
author_facet Alexandra Roi
Simina Boia
Laura-Cristina Rusu
Ciprian Ioan Roi
Eugen Radu Boia
Mircea Riviș
author_sort Alexandra Roi
collection DOAJ
description Oral cancer is currently challenging the healthcare system, with a high incidence among the population and a poor survival rate. One of the main focuses related to this malignancy is the urge to implement a viable approach for improving its early diagnosis. By introducing the use of liquid biopsy and the identification of potential biomarkers, aiming for a noninvasive approach, new advancements offer promising perspectives in the diagnosis of oral cancer. The present review discusses the potential of circulating miRNAs as oral cancer biomarkers identified in body fluids such as serum, plasma, and saliva samples of oral cancer patients. Existing results reveal an important implication of different miRNA expressions involved in the initiation, development, progression, and metastasis rate of oral malignancy. Liquid biomarkers can play a crucial role in the development of the concept of personalized medicine, providing a wide range of clinical applications and future targeted therapies.
first_indexed 2024-03-11T06:53:55Z
format Article
id doaj.art-cc7b5b817a9842069db79eed728f7170
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-11T06:53:55Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-cc7b5b817a9842069db79eed728f71702023-11-17T09:48:11ZengMDPI AGBiomedicines2227-90592023-03-0111396510.3390/biomedicines11030965Circulating miRNA as a Biomarker in Oral Cancer Liquid BiopsyAlexandra Roi0Simina Boia1Laura-Cristina Rusu2Ciprian Ioan Roi3Eugen Radu Boia4Mircea Riviș5Department of Oral Pathology, Multidisciplinary Center for Research, Evaluation, Diagnosis and Therapies in Oral Medicine, “Victor Babes” University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timisoara, RomaniaDepartment of Periodontology, “Victor Babes” University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timisoara, RomaniaDepartment of Oral Pathology, Multidisciplinary Center for Research, Evaluation, Diagnosis and Therapies in Oral Medicine, “Victor Babes” University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timisoara, RomaniaDepartment of Anesthesiology and Oral Surgery, Multidisciplinary Center for Research, Evaluation, Diagnosis and Therapies in Oral Medicine, “Victor Babes” University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 30041 Timisoara, RomaniaDepartment of Ear, Nose and Throat, “Victor Babes” University of Medicine and Pharmacy Timisoara, 2 Eftimie Murgu Sq., 300041 Timisoara, RomaniaDepartment of Anesthesiology and Oral Surgery, Multidisciplinary Center for Research, Evaluation, Diagnosis and Therapies in Oral Medicine, “Victor Babes” University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 30041 Timisoara, RomaniaOral cancer is currently challenging the healthcare system, with a high incidence among the population and a poor survival rate. One of the main focuses related to this malignancy is the urge to implement a viable approach for improving its early diagnosis. By introducing the use of liquid biopsy and the identification of potential biomarkers, aiming for a noninvasive approach, new advancements offer promising perspectives in the diagnosis of oral cancer. The present review discusses the potential of circulating miRNAs as oral cancer biomarkers identified in body fluids such as serum, plasma, and saliva samples of oral cancer patients. Existing results reveal an important implication of different miRNA expressions involved in the initiation, development, progression, and metastasis rate of oral malignancy. Liquid biomarkers can play a crucial role in the development of the concept of personalized medicine, providing a wide range of clinical applications and future targeted therapies.https://www.mdpi.com/2227-9059/11/3/965liquid biopsyoral cancermiRNAearly diagnosisnoninvasivesaliva
spellingShingle Alexandra Roi
Simina Boia
Laura-Cristina Rusu
Ciprian Ioan Roi
Eugen Radu Boia
Mircea Riviș
Circulating miRNA as a Biomarker in Oral Cancer Liquid Biopsy
Biomedicines
liquid biopsy
oral cancer
miRNA
early diagnosis
noninvasive
saliva
title Circulating miRNA as a Biomarker in Oral Cancer Liquid Biopsy
title_full Circulating miRNA as a Biomarker in Oral Cancer Liquid Biopsy
title_fullStr Circulating miRNA as a Biomarker in Oral Cancer Liquid Biopsy
title_full_unstemmed Circulating miRNA as a Biomarker in Oral Cancer Liquid Biopsy
title_short Circulating miRNA as a Biomarker in Oral Cancer Liquid Biopsy
title_sort circulating mirna as a biomarker in oral cancer liquid biopsy
topic liquid biopsy
oral cancer
miRNA
early diagnosis
noninvasive
saliva
url https://www.mdpi.com/2227-9059/11/3/965
work_keys_str_mv AT alexandraroi circulatingmirnaasabiomarkerinoralcancerliquidbiopsy
AT siminaboia circulatingmirnaasabiomarkerinoralcancerliquidbiopsy
AT lauracristinarusu circulatingmirnaasabiomarkerinoralcancerliquidbiopsy
AT ciprianioanroi circulatingmirnaasabiomarkerinoralcancerliquidbiopsy
AT eugenraduboia circulatingmirnaasabiomarkerinoralcancerliquidbiopsy
AT mircearivis circulatingmirnaasabiomarkerinoralcancerliquidbiopsy